Submit an Abstract

Abstract submissions are now closed, however, we are still accepting late-breaking abstracts on a rolling basis. Please contact Ashlee Rhodes at arhodes@acforum.org with questions or for more information. Note that late-breaking abstracts may not be eligible for publication depending on submsssion date.

*New for 2025*

We are pleased to announce that as an added benefit we will be publishing the abstracts presented at the 2025 National Conference in the Research and Practice in Thrombosis and Haemostasis Journal (RPTH)! Individual abstracts will each be assigned a unique DOI and be indexed and searchable in ScienceDirect. Authors who do not wish to be published may still present at the National Conference. We also accepted previously published or presented abstracts as poster sessions, however, these may not be eligible for publication in RPTH.

Abstract Format

All abstracts are limited to a total of 250 words excluding the title, authors, and affiliations. Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, and Conclusions.

Please complete your submission carefully. All abstracts must be in final form. No typos or other errors can be corrected after the deadline. Abstracts will not be considered or reviewed unless all required fields are completed. Authors may edit abstracts online as long as they meet the submission deadline.

We accept original research, case studies, and preliminary research, as well as previously presented abstracts.

Author Notifications

All correspondence, including notification of abstract acceptance and details for poster presentations, will be sent to the Corresponding Author (submitting author) via email. The corresponding author shall be responsible for informing all contributing authors of any related correspondence. At least one author must attend the meeting in order to present the poster. If this presenter is different from the person submitting the abstract you will need to provide their contact information on the submission form.

Additional Guidelines

• The presenting author has the responsibility of obtaining the consent of all coauthors to be listed on the submitted abstract.
• The data reported in the abstract should represent original research. Case studies and research with preliminary results are accepted.
• Abstracts reporting studies with unidentified chemical compounds, drugs, or materials will not be accepted.
• Abstract submission signifies that the reported research complies with animal welfare and human subject regulations.
• Abstract submission signifies permission to post the abstract on the AC Forum web site.
• The abstract itself should contain the following components:
  • The title should accurately reflect the information presented in the body of the abstract.
  • The beginning of the abstract should state the hypothesis, purpose or scientific objective of the study. The remainder of the abstract should address this hypothesis, purpose or scientific objective.
  • The abstract should describe the study, design, subjects and analytic procedures. The method described should unquestionably address the stated hypothesis, purpose or objective. Include enough detail to enable the Program Committee to gain a clear understanding of the methodology.
  • The results should be summarized in sufficient detail to support the final conclusion. If applicable, the mean results should be presented in numerical fashion with deviations or standard errors on the mean. Number of animals, studies or patients should be noted. Present the data in sufficient detail for the reader to form conclusions and acknowledge (or disagree with) the interpretation of the author's analysis.
  • The abstract should close with a brief statement of the conclusion(s). Do not overstate conclusions. Make certain that all conclusions follow logically from the data and that the data presented confirms, refutes or modifies the purpose or the specific objectives of the study in the introductory sentence.
• Each submitted abstract will be evaluated by the Program Committee for scientific merit and compliance with the guidelines described above. Abstracts that do not conform to the above standards may be rejected.

2025 Abstract Poster Categories

• Anticoagulation Clinic Models of Care
• Atrial Fibrillation
• Arterial Thrombosis/PAD/Antiplatelet Therapy
• Anticoagulation Stewardship
• Cardiology/Devices
• COVID-19
• Health Disparities/Social Determinants of Health
• Inpatient Anticoagulation Management
• Laboratory Monitoring
• Patient Self-Testing
• Perioperative Management
• Pediatrics
• Population Health
• Quality Improvements
• Reversal of Anticoagulation
• Special Populations
• Transitions of Care
• Venous Thromboembolism